Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06226051 · ClinicalTrials.gov registry record
Growing Little PEAPODS Study
A clinical trial of Premature Birth and Premature Infant, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT06226051 is a study of Premature Birth and Premature Infant that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 120 participants, below the 391-participant average among 38 other Premature Birth trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06226051, a study of Premature Birth and Premature Infant, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn more about how the food and nutrition babies receive while in the Neonatal Intensive Care Unit (NICU) influences their ability to gain weight and fat-free mass, and their future growth and development. Participants will: * have body growth measurements collected using the PEAPOD device * have nutritional information collected, and * be followed for neurodevelopmental outcomes Participants can expect to be in the study for 36 months.
Conditions Studied
Interventions
- DEVICE PEAPOD Infant Body Composition measuring device
Study Locations (1)
Wisconsin
- Meriter Hospital, Inc. - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-09-04 |
| Est. Completion | 2028-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06226051
The ClinicalTrials.gov registry entry for NCT06226051 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 391-participant average among 38 other Premature Birth trials with a reported enrollment target (69% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Premature Birth appearing as the primary indexed condition, and to 1 intervention - of which PEAPOD Infant Body Composition measuring device is the first listed.
NCT06226051 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06226051 about?
NCT06226051 is a clinical study titled "Growing Little PEAPODS Study". The goal of this clinical trial is to learn more about how the food and nutrition babies receive while in the Neonatal Intensive Care Unit (NICU) influences their ability to gain weight and fat-free mass, and their future growth and development. Participants will: * have body growth measurements c...
What is the current status of trial NCT06226051?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2024-09-04. Estimated completion is 2028-01.
What conditions does trial NCT06226051 study?
This clinical trial studies the following conditions: Premature Birth, Premature Infant, Premature, Intrauterine Growth Restriction, Small for Gestational Age at Delivery.
What interventions are being tested in trial NCT06226051?
The interventions under investigation include: PEAPOD Infant Body Composition measuring device (DEVICE).
Who is sponsoring clinical trial NCT06226051?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06226051 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age
RECRUITING · Phase 4
-
A Randomized Controlled Trial of Impact of Wearable, Wireless Breast Pumps on Frequency and Efficacy of Milk Expression in Mothers of Premature Infants
RECRUITING · NA
-
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
RECRUITING · NA
-
The Periviable GOALS Decision Support Tool
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.